In addition, activating mutations of [i]GNAS[/i] have been identified in adrenal hyperplasia, ovarian cysts, thyroid carcinomas, adrenocortical, pituitary, renal and Leydig cell tumors (17). Here, GNAS is linked to thyroid gland carcinoma.